Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Wenig, Barry

Barry Wenig, MD, MPH, MBA, FACS

Mario D. Mansueto, MD, Professor and Chair

Department of Otolaryngology


Building & Room:

EEI Building


1855 W. Taylor St., Suite 3.87, Chicago, Illinois 60612

Office Phone:


Related Sites:

Otolaryngology Clinic

Building & Room:

Specialty Care Building, 6C


1009 S. Wood St., Chicago, Illinois 60612

Office Phone:



Barry L. Wenig, MD, MPH, MBA, FACS is the Francis L. Lederer Professor of Otolaryngology. He is a widely respected, board-certified otolaryngologist and Director of Head & Neck and Robotic Surgery. He treats patients with malignant and benign tumors of the head and neck, with the goal of eradicating cancer while maintaining quality of life issues such as speech and swallowing function. Dr. Wenig is a nationally recognized expert in robotic surgery as well, and leads the MultiDisciplinary team of surgeons and other clinicians coordinating care of head and neck cancer patients.

Dr. Wenig is a graduate of the Sackler School of Medicine in Tel Aviv, Israel. He did his residency training at Long Island Jewish Medical Center, then fellowship training in Head and Neck Surgical Oncology at The Memorial Sloan Kettering Cancer Center in New York City. He also earned an MPH in Health Policy Administration from the University of Illinois. His list of publications is deep and impressive, numbering more than 100 articles and more than 20 book chapters. Dr. Wenig is a Diplomate of the American Board of Otolaryngology and has been active with a number of professional organizations, including the American Academy of Otolaryngology-Head and Neck Surgery, American Rhinologic Society, American Head and Neck Society, and American College of Surgeons.

Dr. Wenig treats patients with squamous cell carcinoma, thyroid cancer and benign lesions, salivary gland disorders, as well as other benign and malignant problems of the head and neck. Dr. Wenig also treats veterans at the Jesse Brown VA Hospital. Additionally, Dr. Wenig has been nominated to become the Residency Program Director, responsible for Graduate Education within the Department of Otolaryngology - Head and Neck Surgery.


Specialties & Services

  • Ear Nose and Throat
  • Otolaryngology
  • Robotic and Minimally Invasive Surgery
  • Head and Neck Cancer
  • Robotics


  • Distinguished Service Award – American Academy of Otolaryngology-Head and Neck Surgery
  • Academic Excellence Award – Department of Surgery Evanston Northwestern Healthcare
  • Clinical Collaborative Research Program (CCRP) Award “Decide” Trial

Selected Publications

  • Richer SL, Wenig BL. Efficacy of pre-operative screening and treatment of methicilin-resistant Staphylococcus Aureus in an otolaryngology surgical practice. Otolaryngology-Head and Neck Surgery 140: 29-32, 2009
  • Wenig BL, Bayon R. Molecular Targets in the Treatment of Head and Neck Squamous Cell Carcinoma. EMedicine Journal (Serial Journal), 2008
  • Meier J, Wenig BL, Manders, EC. Continuous Intraoperative Facial Nerve Monitoring in Predicting Postoperative Injury During Parotidectomy. Laryngoscope 116: 1169-1172, 2006


Board Certification: Otolaryngology
Residency: Long Island Jewish Hillside Medical Center
Fellowship: Memorial Sloan Kettering Cancer Institute
Internship: Long Island Jewish Hillside Medical Center
Medical School: Sackler School of Medicine Tel Aviv University
Masters in Public Health: University of Illinois
Bachelor of Science: George Washington University, School of Medicine

Professional Memberships

  • American Academy of Otolaryngology
  • American Rhinologic Society
  • American Head and Neck Society
  • American College of Surgeons

Research Currently in Progress

  • Incidence of Venous Thromboembolism in Head and neck Cancer Patients After Resection and Microvascular Free Flap Reconstruction
  • A Phase 3, Randomized, Double-Arm, Open-Label, Controlled Trial of ASP-1929 Photoimmunotherapy Versus Physician’s Choice Standard of Care for the Treatment of Locoregional, Recurrent Head and Neck Squamous Cell Carcinoma in Patients Who Have Failed or Progressed on or After Two Lines of Therapy
  • Transoral Robotic Surgery (TORS) Database